State of Wisconsin Investment Board Portfolio holdings
AUM
$40.9B
1-Year Return
24.31%
This Quarter Return
+0.4%
1 Year Return
+24.31%
3 Year Return
+99.94%
5 Year Return
+177.86%
10 Year Return
+427.44%
AUM
$48.3B
AUM Growth
-$73.8M
(-0.15%)
Cap. Flow
+$248M
Cap. Flow
% of AUM
0.51%
Top 10 Holdings %
Top 10 Hldgs %
19.44%
Holding
2,215
New
156
Increased
1,052
Reduced
474
Closed
103
Top Buys
| 1 |
Pfizer
PFE
|
+$92.1M |
| 2 |
Starbucks
SBUX
|
+$65.4M |
| 3 |
J.M. Smucker
SJM
|
+$62.1M |
| 4 |
ARK Innovation ETF
ARKK
|
+$58.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$58M |
Top Sells
| 1 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$198M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$111M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$103M |
| 4 |
Becton Dickinson
BDX
|
+$78.9M |
| 5 |
American Express
AXP
|
+$74M |
Sector Composition
| 1 | Technology | 23.24% |
| 2 | Financials | 13.95% |
| 3 | Healthcare | 12.7% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Communication Services | 10.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
MasTec
MTZ
$15B
| $607K | ﹤0.01% |
7,035
-2,470
| -26% | -$213K |
|
1627
Albertsons Companies
ACI
$10.4B
| $606K | ﹤0.01% |
19,457
+918
| +5% | +$28.6K |
|
1628
Arcutis Biotherapeutics
ARQT
$2.11B
| $604K | ﹤0.01% |
25,300
| – | – |
|
1629
Costamare
CMRE
$1.46B
| $601K | ﹤0.01% |
+38,774
| New | +$601K |
|
1630
Chemours
CC
$2.44B
| $600K | ﹤0.01% |
20,631
+975
| +5% | +$28.4K |
|
|
STL
1631
DELISTED
Sterling Bancorp
STL
| $598K | ﹤0.01% |
23,944
+1,132
| +5% | +$28.3K |
|
1632
Rithm Capital
RITM
$6.63B
| $597K | ﹤0.01% |
54,232
+2,555
| +5% | +$28.1K |
|
|
AERI
1633
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $597K | ﹤0.01% |
52,400
| – | – |
|
1634
Jackson Financial
JXN
$6.75B
| $591K | ﹤0.01% |
+22,732
| New | +$591K |
|
1635
Premier
PINC
$2.21B
| $591K | ﹤0.01% |
15,248
+721
| +5% | +$27.9K |
|
1636
Ionis Pharmaceuticals
IONS
$10.2B
| $590K | ﹤0.01% |
17,579
+830
| +5% | +$27.9K |
|
1637
Gannett
GCI
$601M
| $587K | ﹤0.01% |
87,935
+25,535
| +41% | +$170K |
|
1638
Crane NXT
CXT
$3.49B
| $586K | ﹤0.01% |
17,801
+858
| +5% | +$28.2K |
|
1639
Travel + Leisure Co
TNL
$4B
| $585K | ﹤0.01% |
10,724
+508
| +5% | +$27.7K |
|
|
POSH
1640
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $584K | ﹤0.01% |
+24,598
| New | +$584K |
|
1641
ICU Medical
ICUI
$3.3B
| $583K | ﹤0.01% |
2,496
+118
| +5% | +$27.6K |
|
1642
Praxis Precision Medicines
PRAX
$847M
| $582K | ﹤0.01% |
2,100
| – | – |
|
1643
Hanover Insurance
THG
$6.37B
| $580K | ﹤0.01% |
4,474
+212
| +5% | +$27.5K |
|
1644
CEMIG Preferred Shares
CIG
$5.81B
| $579K | ﹤0.01% |
388,232
| – | – |
|
1645
Evolus
EOLS
$475M
| $578K | ﹤0.01% |
75,900
+49,200
| +184% | +$375K |
|
|
IMDX
1646
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$85.9M
| $575K | ﹤0.01% |
8,075
+3,026
| +60% | +$215K |
|
|
GAP
1647
The Gap, Inc.
GAP
$8.93B
| $575K | ﹤0.01% |
25,327
-28,019
| -53% | -$636K |
|
1648
Lazard
LAZ
$5.25B
| $574K | ﹤0.01% |
12,536
+374
| +3% | +$17.1K |
|
1649
National Fuel Gas
NFG
$7.87B
| $574K | ﹤0.01% |
10,938
+519
| +5% | +$27.2K |
|
1650
Armstrong World Industries
AWI
$8.47B
| $569K | ﹤0.01% |
5,960
+283
| +5% | +$27K |
|